Saltz LB - Search Results

1

Serum 25-hydroxy vitamin D and survival in advanced colorectal cancer: a retrospective analysis.

Wesa KM, Segal NH, Cronin AM, Sjoberg DD, Jacobs GN, Coleton MI, Fleisher M, Dnistrian AM, Saltz LB, Cassileth BR. Wesa KM, et al. Among authors: saltz lb. Nutr Cancer. 2015;67(3):424-30. doi: 10.1080/01635581.2015.998838. Epub 2015 Feb 3. Nutr Cancer. 2015. PMID: 25646565 Free PMC article.

2

Continuous infusion fluorouracil/leucovorin and bolus mitomycin-C as a salvage regimen for patients with advanced colorectal cancer.

Conti JA, Kemeny NE, Saltz LB, André AM, Grossano DD, Bertino JR. Conti JA, et al. Among authors: saltz lb. Cancer. 1995 Feb 1;75(3):769-74. doi: 10.1002/1097-0142(19950201)75:3<769::aid-cncr2820750304>3.0.co;2-5. Cancer. 1995. PMID: 7828126 Clinical Trial.

3

A fixed-ratio combination of uracil and Ftorafur (UFT) with low dose leucovorin. An active oral regimen for advanced colorectal cancer.

Saltz LB, Leichman CG, Young CW, Muggia FM, Conti JA, Spiess T, Jeffers S, Leichman LP. Saltz LB, et al. Cancer. 1995 Feb 1;75(3):782-5. doi: 10.1002/1097-0142(19950201)75:3<782::aid-cncr2820750306>3.0.co;2-i. Cancer. 1995. PMID: 7828128 Clinical Trial.

4

9-Aminocamptothecin by 72-hour continuous intravenous infusion is inactive in the treatment of patients with 5-fluorouracil-refractory colorectal carcinoma.

Saltz LB, Kemeny NE, Tong W, Harrison J, Berkery R, Kelsen DP. Saltz LB, et al. Cancer. 1997 Nov 1;80(9):1727-32. doi: 10.1002/(sici)1097-0142(19971101)80:9<1727::aid-cncr5>3.0.co;2-b. Cancer. 1997. PMID: 9351540 Clinical Trial.

5

Failure to confirm major objective antitumor activity for streptozocin and doxorubicin in the treatment of patients with advanced islet cell carcinoma.

Cheng PN, Saltz LB. Cheng PN, et al. Among authors: saltz lb. Cancer. 1999 Sep 15;86(6):944-8. Cancer. 1999. PMID: 10491519

6

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group.

Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, Maroun JA, Ackland SP, Locker PK, Pirotta N, Elfring GL, Miller LL. Saltz LB, et al. N Engl J Med. 2000 Sep 28;343(13):905-14. doi: 10.1056/NEJM200009283431302. N Engl J Med. 2000. PMID: 11006366 Free article. Clinical Trial.

7

A phase II study of irinotecan in patients with advanced hepatocellular carcinoma.

O'Reilly EM, Stuart KE, Sanz-Altamira PM, Schwartz GK, Steger CM, Raeburn L, Kemeny NE, Kelsen DP, Saltz LB. O'Reilly EM, et al. Among authors: saltz lb. Cancer. 2001 Jan 1;91(1):101-5. doi: 10.1002/1097-0142(20010101)91:1<101::aid-cncr13>3.0.co;2-k. Cancer. 2001. PMID: 11148565 Clinical Trial.

8

Phase I trial of sequential raltitrexed followed by bolus 5-fluorouracil in patients with advanced colorectal cancer.

Schwartz GK, Bertino J, Kemeny N, Saltz L, Kelsen DK, Tong W, Welch M, Endres S, Dimery I. Schwartz GK, et al. Anticancer Drugs. 2004 Mar;15(3):219-27. doi: 10.1097/00001813-200403000-00005. Anticancer Drugs. 2004. PMID: 15014354 Clinical Trial.

9

Use of surgery among elderly patients with stage IV colorectal cancer.

Temple LK, Hsieh L, Wong WD, Saltz L, Schrag D. Temple LK, et al. J Clin Oncol. 2004 Sep 1;22(17):3475-84. doi: 10.1200/JCO.2004.10.218. J Clin Oncol. 2004. PMID: 15337795

10

Developing a cancer-specific geriatric assessment: a feasibility study.

Hurria A, Gupta S, Zauderer M, Zuckerman EL, Cohen HJ, Muss H, Rodin M, Panageas KS, Holland JC, Saltz L, Kris MG, Noy A, Gomez J, Jakubowski A, Hudis C, Kornblith AB. Hurria A, et al. Cancer. 2005 Nov 1;104(9):1998-2005. doi: 10.1002/cncr.21422. Cancer. 2005. PMID: 16206252 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

423 results

Search Page

Filters